Dr Stephany Standley

Vice President, Oligonucleotide Synthesis and Chemistry at Wave Life Sciences

Speaker

Dr. Standley has been with Wave Life Sciences for over ten years where she serves as Vice President, Oligonucleotide Synthesis and Chemistry. In that time, her focus has been on the high-throughput synthesis of stereopure oligonucleotides for preclinical screening and platform development. Prior to joining Wave, Dr. Standley spent several years at Novartis focused on siRNA design, synthesis and drug delivery vehicle optimization. Dr. Standley received her PhD from UC Berkeley where she studied the utility of polymeric materials for drug delivery purposes. Combined, she has more than twenty years in the field of nucleic acids and drug delivery, investigating multiple oligonucleotide modalities and delivery strategies.